Kovack Advisors, Inc. Astrazeneca PLC Transaction History
Kovack Advisors, Inc.
- $919 Million
- Q3 2024
A detailed history of Kovack Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Kovack Advisors, Inc. holds 2,871 shares of AZN stock, worth $198,271. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,871
Previous 3,060
6.18%
Holding current value
$198,271
Previous $238,000
6.3%
% of portfolio
0.02%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,340Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.34 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.9 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.57 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.54 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.32 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $214B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...